# Zegalogue

NDC: 0169-1912
Generic name: dasiglucagon
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230626

FDA application: NDA214231

## Active ingredients

- DASIGLUCAGON: .6 mg/.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-1912"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-1912
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14704879-872c-4967-8779-04a3bbdfb4e6